<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01477879</url>
  </required_header>
  <id_info>
    <org_study_id>HSV1&amp;2</org_study_id>
    <nct_id>NCT01477879</nct_id>
  </id_info>
  <brief_title>Hsv 1 and 2 Gowey Protocol Versus Placebo</brief_title>
  <official_title>Phase II Clinical Trial of Versabase/Sarracenia Purpurea Versus Placebo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Naturopaths International</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Naturopaths International</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare efficacy of versabase gel with 20% sarracenia purpurea versus placebo
      applied every 3-4 hours to herpes lesions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients screened for hsv one or two. Patients with herpes given a 1/8 oz of gel. Researcher
      does not know which is active and which is placebo (placebo is actually just versabase gel).
      Patent applies gel to lesions every 3-4 hours. Returns to clinic on days 3, 5, and 14 for
      evaluation. Up to 50 patients may be enrolled.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>2 weeks</time_frame>
    <description>Pain scale-- subjective</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Size</measure>
    <time_frame>2 weeks</time_frame>
    <description>Measure lesion size over 2 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Appearance</measure>
    <time_frame>2 weeks</time_frame>
    <description>Photo taken of lesion w patient informed consent</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Herpes</condition>
  <arm_group>
    <arm_group_label>Versabase/20% S. purpurea extract</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo (versabase gel only)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo used will be versabase gel alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Versabase gel with sarracenia purpurea 20% liquid extract</intervention_name>
    <description>Topical application of gel/plant mix to lesions</description>
    <arm_group_label>Versabase/20% S. purpurea extract</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo (versabase gel only)</intervention_name>
    <description>versabase gel only</description>
    <arm_group_label>placebo (versabase gel only)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Hsv 1&amp;2

        Exclusion Criteria:

          -  No active lesions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Naturopaths international</name>
      <address>
        <city>Flagstaff</city>
        <state>Arizona</state>
        <zip>86001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 15, 2011</study_first_submitted>
  <study_first_submitted_qc>November 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 23, 2011</study_first_posted>
  <last_update_submitted>November 19, 2011</last_update_submitted>
  <last_update_submitted_qc>November 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 23, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Naturopaths International</investigator_affiliation>
    <investigator_full_name>Dr. Brandie Gowey, NMD</investigator_full_name>
    <investigator_title>Brandie Gowey</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

